Bafna Pharmaceuticals Limited (BAFNAPH) — Free Cash Flow Generation Index
Bafna Pharmaceuticals Limited (BAFNAPH) has a Free Cash Flow Generation Index of -0.76x as of September 2025. Free cash flow of Rs-71.04 Million represents -1% of operating cash flow (Rs93.12 Million). Explore reinvestment intensity of Bafna Pharmaceuticals Limited to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Bafna Pharmaceuticals Limited Free Cash Flow Generation Index (2007–2026)
Historical FCF Generation Index trend for Bafna Pharmaceuticals Limited across 10 annual periods. For the full cash flow conversion analysis, see BAFNAPH cash flow metrics.
Annual Free Cash Flow Generation for Bafna Pharmaceuticals Limited (2007–2026)
Year-by-year Free Cash Flow Generation Index for Bafna Pharmaceuticals Limited. Check Bafna Pharmaceuticals Limited (BAFNAPH) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | -1.11x | Rs-130.76 Million | Rs118.27 Million | Rs249.03 Million | ▼ -826.5% |
| 2025 | -0.12x | Rs-23.31 Million | Rs195.29 Million | Rs218.60 Million | ▲ +81.4% |
| 2024 | -0.64x | Rs-60.93 Million | Rs94.85 Million | Rs155.78 Million | ▲ +2.6% |
| 2023 | -0.66x | Rs-32.66 Million | Rs49.52 Million | Rs82.19 Million | ▼ -393.3% |
| 2022 | 0.22x | Rs21.87 Million | Rs97.28 Million | Rs75.41 Million | ▲ +114.7% |
| 2016 | -1.53x | Rs-13.96 Million | Rs9.11 Million | Rs23.07 Million | ▼ -668.4% |
| 2015 | 0.27x | Rs28.75 Million | Rs106.65 Million | Rs77.90 Million | ▲ +395.6% |
| 2014 | -0.09x | Rs-1.46 Million | Rs16.06 Million | Rs17.53 Million | ▼ -109.7% |
| 2013 | 0.94x | Rs345.05 Million | Rs366.32 Million | Rs21.28 Million | ▲ +210.7% |
| 2007 | -0.85x | Rs-85.96 Million | Rs101.06 Million | Rs187.01 Million | — |